Overview | Medtronic
Medtronic Investors

Creating
Long-term
Shareholder
Value

Our leading technologies and services create value on a global scale.

Learn More

Latest Investor Information

January 08, 2018
Medtronic plc at the 36th Annual J.P. Morgan Healthcare Conference
January 08, 2018
Medtronic plc at the 36th Annual J.P. Morgan Healthcare Conference - Q&A
December 06, 2017
Citi 2017 Global Healthcare Conference
November 21, 2017
Q2 2018 Medtronic plc Earnings Conference Call

Latest Press Releases

January 16, 2018Medtronic Receives FDA Clearance for Riptide(TM) Aspiration System
January 11, 2018New Study Shows Superiority of Intrathecal Baclofen Therapy (ITB Therapy(SM)) Over Oral Medication for the Treatment of Severe Post-Stroke Spasticity
January 10, 2018FDA Approves Innovative Clinician Programmer for the Medtronic SynchroMed II Intrathecal Drug Delivery System for Chronic Pain and Severe Spasticity
January 09, 2018Medtronic Enrolls First Patient In Pain Study to Assess Optimized Spinal Cord Stimulation Programming
Read More

Medtronic ESG & Corporate Citizenship Highlights

Medtronic Marks a Decade on the North American Dow Jones Sustainability Index (DJSI)

LEARN MORE

Opportunities to Obtain Irish Dividend Withholding Tax (DWT) Exemption

Important Information on the Irish Dividend Withholding Tax.

LEARN MORE

QUARTERLY

RESULTS

Medtronic Q2 revenue results and financial tables.

LEARN MORE

INVESTOR

FUNDAMENTALS

View snapshots of revenue and earnings, trading statistics, balance sheet, income statement, cash flow and ratios.

LEARN MORE
img.alt

Sustainability Index Endorsements

Read more about our Sustainability efforts.

READ MORE
 
img.alt

Medtronic Spotlight

CNBC’s Meg Tirrell talks to Medtronic CEO Omar Ishrak at the Piper Jaffray Healthcare Heartland Summit about growth, pricing and other challenges facing the industry.

Play Video
 
img.alt

Focus on Patients

The personal connection between Medtronic plc, its employees and patients.

Play Video
 
img.alt

History of Medtronic

A video history of the company.

Play Video

Investor Contacts

Stock Transfer Agent

Wells Fargo Shareowner Services
+1 888-648-8154

Medtronic Investor Relations Department

investor.relations@medtronic.com

+1 763-505-2692

Ryan Weispfenning

Vice President, Investor Relations

View All
X